HIKMA PHARMACEUTICALS PLC Hikma Pharmaceuticals PLC - Vesting of 2014 EIP
LONDON, 11 April 2017: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) ('Hikma') announces that the following Persons Discharging Managerial Responsibility ('PDMR') have received shares as a result of the vesting of their conditional share awards on 10 April 2017 under the 2014 Executive Incentive Plan ('EIP') which was completed on 11 April 2017. These awards were automatically exercised by operation of the conditional award and vesting process. The exercise price under the EIP is £nil. As indicated in the table below, certain PDMRs have made disposals.
Notification and public disclosure of transactions by persons discharging managerial responsibilities
1 | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | Khalid Nabilsi |
2 | Reason for the notification | |
a) | Position/status | Chief Financial Officer |
b) | Initial notification /Amendment | Initial notification |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | Hikma Pharmaceuticals PLC |
b) | LEI | 549300BNS685UXH4JI75 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
b) | Nature of the transaction | Shares acquired from vesting of the conditional awards on 10 April 2017 under the 2014 Executive Incentive Plan (EIP). |
c) | Price(s) and volume(s) | Price(s): £nil Volume(s): 14,165 |
d) | Aggregated information | N/A |
e) | Date of the transaction | 10 April 2017 |
f) | Place of the transaction | London Stock Exchange (XLON) |
1 | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | Riad Mishlawi |
2 | Reason for the notification | |
a) | Position/status | EU Vice President and Global Head of Injectables |
b) | Initial notification /Amendment | Initial notification |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | Hikma Pharmaceuticals PLC |
b) | LEI | 549300BNS685UXH4JI75 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
b) | Nature of the transaction | Shares acquired from vesting of the conditional awards on 10 April 2017 under the 2014 Executive Incentive Plan (EIP). |
c) | Price(s) and volume(s) | Price(s): £nil Volume(s): 13,811 |
d) | Aggregated information | N/A |
e) | Date of the transaction | 10 April 2017 |
f) | Place of the transaction | London Stock Exchange (XLON) |
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||||
a) | Name | Michael Raya | ||||||
2 | Reason for the notification | |||||||
a) | Position/status | CEO of West-Ward Pharmaceuticals | ||||||
b) | Initial notification /Amendment | Initial notification | ||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
a) | Name | Hikma Pharmaceuticals PLC | ||||||
b) | LEI | 549300BNS685UXH4JI75 | ||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 | ||||||
b) | Nature of the transaction | Shares acquired and disposed from vesting of the conditional awards on 10 April 2017 under the 2014 Executive Incentive Plan (EIP). 7,902 shares were sold to cover tax and associated costs and 11,753 shares were retained. | ||||||
c) | Price(s) and volume(s) |
| ||||||
d) | Aggregated information | £20.00 £158,040 | ||||||
e) | Date of the transaction | 10 April 2017 | ||||||
f) | Place of the transaction | London Stock Exchange (XLON) | ||||||
1 | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | Bassam Kanaan |
2 | Reason for the notification | |
a) | Position/status | Chief Strategy and Corporate Development Officer |
b) | Initial notification /Amendment | Initial notification |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | Hikma Pharmaceuticals PLC |
b) | LEI | 549300BNS685UXH4JI75 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
b) | Nature of the transaction | Shares acquired from vesting of the conditional awards on 10 April 2017 under the 2014 Executive Incentive Plan (EIP). |
c) | Price(s) and volume(s) | Price(s): £nil Volume(s): 19,945 |
d) | Aggregated information | N/A |
e) | Date of the transaction | 10 April 2017 |
f) | Place of the transaction | London Stock Exchange (XLON) |
1 | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | Majda Labadi |
2 | Reason for the notification | |
a) | Position/status | Corporate Vice President for Human Resources and Head of Operations, MENA |
b) | Initial notification /Amendment | Initial notification |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | Hikma Pharmaceuticals PLC |
b) | LEI | 549300BNS685UXH4JI75 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
b) | Nature of the transaction | Shares acquired from vesting of the conditional awards on 10 April 2017 under the 2014 Executive Incentive Plan (EIP). |
c) | Price(s) and volume(s) | Price(s): £nil Volume(s): 10,089 |
d) | Aggregated information | N/A |
e) | Date of the transaction | 10 April 2017 |
f) | Place of the transaction | London Stock Exchange (XLON) |
Hikma Pharmaceuticals plc published this content on 11 April 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 20 April 2017 01:05:04 UTC.
Original documenthttp://otp.investis.com/clients/uk/hikma/rns/regulatory-story.aspx?cid=167&newsid=863523
Public permalinkhttp://www.publicnow.com/view/B291E3E96DA0754661589A16E3C9F61E85BF5331
